Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Direct oral anticoagulants: Still too early for prime time after pulmonary endarteriectomy?

Bertoletti L, Jaïs X, Bezzeghoud S, Delavenne X.

J Thromb Haemost. 2020 Mar;18(3):758-759. doi: 10.1111/jth.14706. No abstract available.

PMID:
32112534
2.

"Rehab for all!" Is it too early in pulmonary arterial hypertension?

Bertoletti L, Bouvaist H, Tromeur C, Bezzeghoud S, Dauphin C, Enache I, Bourdin A, Seronde MF, Montani D, Turquier S, Pison C; FONCE-HTAP investigators; Steering committee.

Eur Respir J. 2019 Nov 7;54(5). pii: 1901558. doi: 10.1183/13993003.01558-2019. Print 2019 Nov. No abstract available.

PMID:
31699779
3.

Indications and potential pitfalls of anticoagulants in pulmonary hypertension: Would DOACs become a better option than VKAs?

Margelidon-Cozzolino V, Delavenne X, Catella-Chatron J, De Magalhaes E, Bezzeghoud S, Humbert M, Montani D, Bertoletti L.

Blood Rev. 2019 Sep;37:100579. doi: 10.1016/j.blre.2019.05.003. Epub 2019 May 15. Review.

PMID:
31113643
4.

Cancer incidence in patients with pre-capillary pulmonary hypertension.

Bravos E, Cottin V, Dauphin C, Bouvaist H, Traclet J, Trésorier R, Margelidon-Cozzolino V, Bezzeghoud S, Ahmad K, Accassat S, De Magalhaes E, Mornex JF, Pison C, Bertoletti L.

J Heart Lung Transplant. 2019 Jul;38(7):778-780. doi: 10.1016/j.healun.2019.03.007. Epub 2019 Mar 15. No abstract available.

PMID:
30962146

Supplemental Content

Loading ...
Support Center